Aptus Capital Advisors LLC Boosts Stock Holdings in Amdocs Limited $DOX

Key Points

• Aptus Capital Advisors LLC increased its stake in Amdocs Limited (NASDAQ: DOX) by 13% in Q1, now owning 49,403 shares valued at approximately $4.52 million.
• Amdocs has announced a quarterly dividend of $0.527 per share, with an annualized yield of 2.4%, payable on October 31st to shareholders of record by September 30th.
• The company reported earnings of $1.72 EPS for the last quarter, exceeding analysts' expectations, but its revenue declined by 8.4% year-over-year.

Aptus Capital Advisors LLC boosted its holdings in shares of Amdocs Limited (NASDAQ:DOX - Free Report) by 13.0% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 49,403 shares of the technology company's stock after acquiring an additional 5,676 shares during the period. Aptus Capital Advisors LLC's holdings in Amdocs were worth $4,520,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in DOX. Cornerstone Planning Group LLC purchased a new stake in shares of Amdocs during the first quarter valued at about $27,000. AdvisorNet Financial Inc lifted its position in shares of Amdocs by 382.9% during the first quarter. AdvisorNet Financial Inc now owns 338 shares of the technology company's stock valued at $31,000 after buying an additional 268 shares during the last quarter. NBC Securities Inc. purchased a new stake in shares of Amdocs during the first quarter valued at about $31,000. Cullen Frost Bankers Inc. purchased a new stake in Amdocs in the first quarter valued at about $39,000. Finally, Tower Research Capital LLC TRC raised its stake in Amdocs by 55.0% in the fourth quarter. Tower Research Capital LLC TRC now owns 586 shares of the technology company's stock valued at $50,000 after buying an additional 208 shares during the last quarter. 92.02% of the stock is currently owned by institutional investors.

Amdocs Stock Performance

DOX traded down $0.7580 during trading on Monday, reaching $87.5120. 94,581 shares of the company's stock were exchanged, compared to its average volume of 715,474. Amdocs Limited has a 1 year low of $78.61 and a 1 year high of $95.41. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.22 and a quick ratio of 1.22. The stock has a market capitalization of $9.88 billion, a P/E ratio of 17.76, a price-to-earnings-growth ratio of 1.61 and a beta of 0.51. The company's fifty day simple moving average is $89.14 and its 200-day simple moving average is $88.79.

Amdocs (NASDAQ:DOX - Get Free Report) last announced its quarterly earnings results on Wednesday, August 6th. The technology company reported $1.72 earnings per share for the quarter, beating the consensus estimate of $1.71 by $0.01. The company had revenue of $1.14 billion during the quarter, compared to analysts' expectations of $1.13 billion. Amdocs had a return on equity of 19.66% and a net margin of 11.94%.Amdocs's quarterly revenue was down 8.4% on a year-over-year basis. During the same period last year, the business earned $1.62 earnings per share. As a group, research analysts predict that Amdocs Limited will post 6.21 earnings per share for the current fiscal year.

Amdocs Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Tuesday, September 30th will be issued a dividend of $0.527 per share. This represents a $2.11 annualized dividend and a dividend yield of 2.4%. The ex-dividend date of this dividend is Tuesday, September 30th. Amdocs's payout ratio is 42.80%.

Wall Street Analyst Weigh In

DOX has been the subject of several research analyst reports. Wolfe Research initiated coverage on shares of Amdocs in a research report on Tuesday, July 8th. They issued an "outperform" rating for the company. Wall Street Zen raised shares of Amdocs from a "hold" rating to a "buy" rating in a research report on Sunday, August 10th. Four equities research analysts have rated the stock with a Buy rating, According to MarketBeat, the company presently has a consensus rating of "Buy" and a consensus target price of $105.33.

Amdocs Profile

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.